<< Back


Heidi Hagen

Ms. Hagen, an experienced and entrepreneurial biotechnology operations executive, joined Ziopharm’s Board in June 2019. She is Co-Founder and Advisor of Vineti, a cloud-based software platform company that addresses challenges in data management from order through cell collection, manufacturing, and delivery of personalized treatments such as cell and gene therapies and cancer vaccines. Beginning her career at Immunex Corporation, Ms. Hagen worked for ten years in a range of roles in drug development and operations management. Following Immunex, she served as Senior Vice President of Operations for more than a decade at Dendreon. More recently, she was the Global Chief Operating Officer for SOTIO, a diverse pharmaceutical company specializing in oncology, based in Prague.  Ms. Hagen also serves on the board of directors for Vericel, a commercial-stage biopharmaceutical company specializing on cellular therapies for sports medicine and severe burn care markets. She has a B.S. in Cell and Molecular Biology, an M.S. in Bioengineering, and an MBA from the University of Washington.